Al Za'abi Mohammed, Al Muqbali Juhina, Al-Waili Khalid
Department of Pharmacology & Clinical Pharmacy, College of Medicine & Health Sciences, Sultan Qaboos University, Oman.
Department of Biochemistry, College of Medicine & Health Sciences, Sultan Qaboos University, Oman.
Saudi Pharm J. 2015 Sep;23(4):458-62. doi: 10.1016/j.jsps.2014.11.005. Epub 2014 Nov 24.
To evaluate prospectively the appropriateness of indications, sampling time and outcome of TDM requests at a teaching university hospital in Oman.
A prospective cross-sectional study was conducted over a four months period; October 2013-January 2014 at the Sultan Qaboos University Hospital (SQUH), an 855 bed university teaching hospital. Appropriateness criteria for indications and sampling time were defined a priori. The evaluated drug's requests were for carbamazepine, phenytoin, phenobarbital, valproic acid, digoxin, gentamicin, amikacin, vancomycin, tobramycin, theophylline, lithium, and cyclosporine.
Of 733 evaluated TDM requisitions, the majority were for antibiotics (75.0%) followed by antiepileptics (10.5%) and cyclosporine (8.9%). Most of the requests had appropriate indication (78.2%), however, only 28.5% had appropriate sampling time. RESULTS were applied by dosage adjustments in 65.8% of requests and some of the inappropriately sampled requests (15.3%) were used as a basis for modifying the dosage regimen. Of all the reported plasma concentrations 42.3%, 41.2%, and 16.5% were within, below and above the reference range, respectively.
TDM service is much less than optimal in SQUH. A lot of effort needs to be carried out to improve TDM use in the developing countries as adjusting the doses on results that are based on wrong sampling time might expose patients to toxicity or therapeutic failure.
前瞻性评估阿曼一所教学型大学医院中治疗药物监测(TDM)申请的适应症、采样时间及结果的合理性。
于2013年10月至2014年1月的四个月期间,在拥有855张床位的苏丹卡布斯大学医院(SQUH)进行了一项前瞻性横断面研究。事先定义了适应症和采样时间的合理性标准。所评估药物的申请涉及卡马西平、苯妥英、苯巴比妥、丙戊酸、地高辛、庆大霉素、阿米卡星、万古霉素、妥布霉素、茶碱、锂和环孢素。
在733份评估的TDM申请中,大多数是抗生素(75.0%),其次是抗癫痫药(10.5%)和环孢素(8.9%)。大多数申请有合适的适应症(78.2%),然而,只有28.5%的申请采样时间合适。65.8%的申请根据结果进行了剂量调整,一些采样时间不合适的申请(15.3%)被用作修改给药方案的依据。在所有报告的血浆浓度中,分别有42.3%、41.2%和16.5%在参考范围内、低于参考范围和高于参考范围。
SQUH的TDM服务远未达到最佳状态。在发展中国家,需要付出很多努力来改善TDM的使用,因为根据错误采样时间的结果调整剂量可能会使患者面临毒性或治疗失败的风险。